![](\"http:\/\/www.erzurumflas.com\/wp-content\/uploads\/2020\/12\/cinde-covid-19a-karsi-toplu-asilama-icin-onay-bekleniyor_eb93b3c.jpg\")
\u00c7in\u2019de Covid-19 a\u015f\u0131s\u0131n\u0131n toplu kullan\u0131m\u0131 i\u00e7in resmi onay\u0131n \u00f6n\u00fcm\u00fczdeki g\u00fcnlerde \u00e7\u0131kmas\u0131 bekleniyor.<\/p>\n\u00c7in\u2019de Covid-19 a\u015f\u0131s\u0131n\u0131n toplu kullan\u0131m\u0131 i\u00e7in resmi onay\u0131n \u00f6n\u00fcm\u00fczdeki g\u00fcnlerde \u00e7\u0131kmas\u0131 bekleniyor.<\/p>\n
\u0130ngiltere\u2019nin Pfizer ve BioNTech\u2019in ortak geli\u015ftirdi\u011fi Covid-19 a\u015f\u0131s\u0131na acil kullan\u0131m onay\u0131 vermesinin ard\u0131ndan, \u00c7in\u2019deki ila\u00e7 \u015firketlerinin geli\u015ftirdi\u011fi a\u015f\u0131lar i\u00e7in de onay \u00e7al\u0131\u015fmalar\u0131 h\u0131z kazand\u0131. \u00c7in Ba\u015fbakan Yard\u0131mc\u0131s\u0131 Sun Chunlan, ge\u00e7ti\u011fimiz \u00e7ar\u015famba g\u00fcn\u00fc Ulusal G\u0131da ve \u0130la\u00e7 Kontrol\u00fc \u0130daresi ile Covid-19 a\u015f\u0131s\u0131 geli\u015ftirme yar\u0131\u015f\u0131nda ba\u015f\u0131 \u00e7eken Sinovac ve Sinopharm firmalar\u0131n\u0131 ziyaret etti. \u0130ki \u015firketin \u00fcretim hatlar\u0131nda incelemelerde bulunan Chunlan, \u015firketlerin geni\u015f \u00f6l\u00e7ekli a\u015f\u0131 \u00fcretimi i\u00e7in haz\u0131r olmalar\u0131 \u00e7a\u011fr\u0131s\u0131nda bulundu.<\/p>\n
\u00c7in devlet medyas\u0131 ise Chunlan\u2019\u0131n Devlet Konseyi \u00dcyesi Wang Yong ile yapt\u0131\u011f\u0131 ziyaretleri \u00c7in\u2019de Covid-19 a\u015f\u0131s\u0131n\u0131n piyasaya sunulmas\u0131n\u0131n yakla\u015ft\u0131\u011f\u0131n\u0131n i\u015fareti olarak de\u011ferlendirdi. \u00c7inli uzmanlar, \u00fclkenin y\u0131l sonuna kadar 600 milyon doz a\u015f\u0131n\u0131n kullan\u0131m\u0131na onay vermeyi planlad\u0131\u011f\u0131n\u0131 a\u00e7\u0131klam\u0131\u015ft\u0131. \u00c7in\u2019de a\u015f\u0131lar\u0131n toplu olarak kullan\u0131m\u0131na Aral\u0131k ay\u0131 i\u00e7inde resm\u00ee onay verilmesi bekleniyor, ancak a\u015f\u0131lar\u0131n kullan\u0131m kapsam\u0131, \u00f6l\u00e7e\u011fi ve fiyat\u0131 konular\u0131nda belirsizlikler s\u00fcr\u00fcyor.<\/p>\n
\u00c7inli \u015firketler son a\u015faman\u0131n verilerini a\u00e7\u0131klamad\u0131<\/p>\n
\u00c7inli \u015firketler, a\u015f\u0131lardaki denemelerin son a\u015famaya geldiklerini belirtmelerine ra\u011fmen, hen\u00fcz testlere dair verileri sunmad\u0131. Sinopharm ve Sinovac\u2019\u0131n a\u015f\u0131lar\u0131n\u0131n acil kullan\u0131m\u0131 klinik deneyler hen\u00fcz tamamlanmadan onaylanm\u0131\u015ft\u0131.<\/p>\n
Sinovac\u2019\u0131n CEO\u2019su Yin Weidong Eyl\u00fcl ay\u0131nda yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, g\u00f6n\u00fcll\u00fclerin y\u00fczde 97-98\u2019inin antikor geli\u015ftirdi\u011fini ifade etmi\u015fti. \u015eirketin y\u0131ll\u0131k 300 milyon doz a\u015f\u0131 \u00fcretmek i\u00e7in kapasitesini art\u0131rd\u0131\u011f\u0131 belirtilmi\u015fti.<\/p>\n
Pfizer-BioNTech, geli\u015ftirdi\u011fi a\u015f\u0131ya dair son tahlillerin a\u015f\u0131n\u0131n hastalar \u00fczerinde y\u00fczde 95 oran\u0131nda etkili oldu\u011funu g\u00f6sterdi\u011fini bildirmi\u015fti. D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc\u2019n\u00fcn (DS\u00d6) a\u015f\u0131lar\u0131n etkisi ve g\u00fcvenli\u011fine dair ikna edici veriler sa\u011flanmad\u0131k\u00e7a, acil durum kullan\u0131m lisans\u0131 vermesinin zor oldu\u011fu belirtiliyor.<\/p>\n
\u0130lk onaylar Sinovac ile Sinopharm\u2019\u0131n a\u015f\u0131lar\u0131na verilecek<\/p>\n
\u00c7in\u2019de Sinovac ve Sinopharm\u2019\u0131n geli\u015ftirdi\u011fi inaktif a\u015f\u0131lar\u0131n ilk onay alacak a\u015f\u0131lar olmas\u0131 bekleniyor. \u00dclkede, Covid-19 a\u015f\u0131s\u0131ndan \u00f6ncelikle liman i\u015f\u00e7ileri ve sa\u011fl\u0131k personeli gibi y\u00fcksek riskli gruplar\u0131n faydalanaca\u011f\u0131 belirtildi.<\/p>\n
\u00c7inli \u015firketler taraf\u0131ndan geli\u015ftirilen 4\u2019\u00fc inaktif a\u015f\u0131 olmak \u00fczere 6 Covid-19 a\u015f\u0131s\u0131nda 3. a\u015fama klinik deneylere ge\u00e7ildi. A\u015f\u0131lardan ikisi, devlete ba\u011fl\u0131 Sinopharm \u015firketine ait olurken, a\u015f\u0131lar\u0131n insanl\u0131 deneyleri Temmuz ay\u0131 ortas\u0131nda Birle\u015fik Arap Emirlikleri\u2019nde (BAE) ba\u015flam\u0131\u015ft\u0131.<\/p>\n
Ba\u015fkent Pekin merkezli Sinovac \u015firketi de Temmuz ay\u0131nda CoronaVac adl\u0131 a\u015f\u0131s\u0131n\u0131n son a\u015fama deneylerini Brezilya\u2019da ba\u015flatm\u0131\u015ft\u0131. A\u015f\u0131 yar\u0131\u015f\u0131nda iddial\u0131 \u015firketlerden bir di\u011feri de Eyl\u00fcl ortas\u0131nda 3. a\u015fama klinik deneylere ge\u00e7ildi\u011fini duyuran CanSino Biologics olmu\u015ftu.<\/p>\n
\u00c7in\u2019de 1 milyondan fazla ki\u015fi a\u015f\u0131land\u0131<\/p>\n
\u00c7in devlet medyas\u0131nda \u00e7\u0131kan haberlere g\u00f6re, \u00fclkede \u015fu ana kadar 1 milyondan fazla ki\u015fiye a\u015f\u0131 yap\u0131ld\u0131\u011f\u0131 belirtildi. Sinopharm Y\u00f6netim Kurulu Ba\u015fkan\u0131 Liu Jingzhen Kas\u0131m ay\u0131nda yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, acil kullan\u0131m program\u0131 kapsam\u0131nda yakla\u015f\u0131k 1 milyon ki\u015fiye a\u015f\u0131 yap\u0131ld\u0131\u011f\u0131n\u0131 ve g\u00f6n\u00fcll\u00fcler \u00fczerinde herhangi ciddi yan etki g\u00f6r\u00fclmedi\u011fini ifade etmi\u015fti.<\/p>\n
\u00c7inli uzmanlar, inaktif a\u015f\u0131lar\u0131n daha etkili ve g\u00fcvenli oldu\u011funa dikkat \u00e7ekiyor. S\u00f6z konusu a\u015f\u0131lar\u0131n bir di\u011fer avantaj\u0131 ise 2-8 santigrat derece aral\u0131\u011f\u0131nda saklanabildikleri i\u00e7in so\u011fuk zincirde ta\u015f\u0131nmas\u0131n\u0131 kolay olmas\u0131 g\u00f6steriliyor. Pfizer-BioNTech ve Moderna taraf\u0131ndan geli\u015ftirilen a\u015f\u0131lar\u0131n\u0131n eksi 70-20 santigrat derecede saklanma gereklili\u011fi so\u011fuk zincir tedarikini zorla\u015ft\u0131r\u0131rken, maliyeti de y\u00fckseltiyor.<\/p>\n
\u00c7in bas\u0131n\u0131ndaki haberlerde, \u00c7in\u2019de be\u015f farkl\u0131 metotla en az 14 ayr\u0131 Covid-19 a\u015f\u0131s\u0131 geli\u015ftirildi\u011fi belirtiliyor. D\u00fcnya genelinde geli\u015ftirilen 214 a\u015f\u0131 aday\u0131ndan 14\u2019\u00fcnde son a\u015fama klinik deneyler yap\u0131l\u0131yor.<\/p>\n
\u00c7in\u2019de a\u015f\u0131n\u0131n fiyat\u0131 belirsiz<\/p>\n
Sinovac, geli\u015ftirdi\u011fi a\u015f\u0131 i\u00e7in resm\u00ee olarak bir \u00fccret belirlemezken, yerel d\u00fczeyde farkl\u0131 fiyatland\u0131rmalar bas\u0131na yans\u0131yor. \u00c7in\u2019in do\u011fusundaki Jiaxing kentideki yetkililer, 200 yuan (yakla\u015f\u0131k 30 dolar) kar\u015f\u0131l\u0131\u011f\u0131nda y\u00fcksek riskli gruplardan ki\u015filerin bir doz a\u015f\u0131 yapt\u0131rabilece\u011fini a\u00e7\u0131klad\u0131. Sichuan ve Anhui eyaletleri de ayn\u0131 a\u015f\u0131n\u0131n iki dozu i\u00e7in 400 yuanl\u0131k fiyat belirledi.<\/p>\n
Sinopharm, ise A\u011fustos ay\u0131nda iki doz a\u015f\u0131 i\u00e7in fiyat\u0131n\u0131n 1000 yuan\u0131 (150 dolar) ge\u00e7meyece\u011fini duyurmu\u015ftu.<\/p>\n
\u00c7in\u2019de son durum<\/p>\n
\u00c7in\u2019de d\u00fcn 18 yeni vaka tespit edilirken, vakalardan 1\u2019inin yerel kaynakl\u0131, di\u011ferlerinin ise yurt d\u0131\u015f\u0131 kaynakl\u0131 oldu\u011fu bildirildi. Yerel kaynakl\u0131 vakan\u0131n Tianjin kentinde saptand\u0131\u011f\u0131 aktar\u0131ld\u0131.<\/p>\n
\u00dclkede salg\u0131n\u0131n ba\u015f\u0131ndan bu yana 86 bin 619 teyitli vaka kay\u0131tlara ge\u00e7erken, 4 bin 634 ki\u015fi ya\u015fam\u0131n\u0131 yitirdi.<\/p>\n
Salg\u0131n\u0131n ba\u015flad\u0131\u011f\u0131 Wuhan\u2019da ise sa\u011fl\u0131k birimleri, kentteki ithal domuz ve s\u0131\u011f\u0131r eti paketlerinde korona vir\u00fcs tespit edildi\u011fini a\u00e7\u0131klad\u0131. \u00dcr\u00fcnlerin Brezilya\u2019dan ve Uruguay\u2019dan ithal edildi\u011fi bilgisi verildi. \u00dcr\u00fcnlerin sakland\u0131\u011f\u0131 b\u00f6lgelerin dezenfekte edildi\u011fi, ilgili personele de test yap\u0131ld\u0131\u011f\u0131 belirtildi.<\/p>\n","protected":false},"excerpt":{"rendered":"
\u00c7\u0130N\u2019DE COV\u0130D-19\u2019A KAR\u015eI TOPLU A\u015eILAMA \u0130\u00c7\u0130N ONAY BEKLEN\u0130YOR<\/p>\n","protected":false},"author":1,"featured_media":1551616,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,20],"tags":[116335,34231,18390,21866,13197,15443,7930,15104],"class_list":["post-1551615","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gundem","category-turkiye","tag-covid-19a","tag-asilama","tag-bekleniyor","tag-cinde","tag-icin","tag-karsi","tag-onay","tag-toplu"],"_links":{"self":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1551615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1551615"}],"version-history":[{"count":0,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/posts\/1551615\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=\/wp\/v2\/media\/1551616"}],"wp:attachment":[{"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1551615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1551615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erzhaber.com.tr\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1551615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}